- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ad Stars: GSW Worldwide (Tamiflu)
"!-- -->
BRING ON THE PENGUINS
agency: GSW Worldwide
brand: Tamiflu
client: Roche
photo from left: Bruce Rooke, chief creative officer • Scott Tannenbaum, SVP, director of client services
An unbranded campaign can help move the mark, especially when you've got adorable computer-animated penguins from the movie Happy Feet as the stars. Roche and GSW licensed the cute critters from Warner Bros., and then used them to reach beyond Big Pharma's usual sphere of influence—right into the American multiplex, where they could target mothers and children at the same time during the flu season.
The execution of the pre-movie commercials wasn't easy: "There were a lot of moving pieces and parts to this," says GSW's Scott Tannenbaum. "We licensed music from Stevie Wonder. We had to get him to approve it, Roche to approve it, and Warner Bros. to approve it. It was complex but clearly well worth the effort." The result? Great traffic for the campaign Web site, FluFacts.com, and great sales for Tamiflu.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
